Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome

To improve patient quality of life and reduce health care costs, many conditions formerly thought to require inpatient care are now treated in the outpatient setting. Outpatient induction chemotherapy for acute myeloid leukemia (AML) may confer similar benefits. This possibility prompted a pilot stu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Mabrey, Frances Linzee, Gardner, Kelda M., Shannon Dorcy, Kathleen, Perdue, Andrea, Smith, Heather A., Davis, Alicyn M., Hammer, Cody, Rizzuto, Donelle, Jones, Sunny, Quach, Kim, Scott, Bart L., Hendrie, Paul C., Percival, Mary-Elizabeth M., Walter, Roland B., Appelbaum, Frederick R., Estey, Elihu H., Becker, Pamela S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Clinical Trials and Observations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7042997/
https://ncbi.nlm.nih.gov/pubmed/32074276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000707
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados